Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C

Liver

Volumn 19, Issue 3, 1999, Pages 212-219

  Baroni, Gianluca Svegliati ^a   Pastorelli, Alfredo ^b   Manzin, Aldo ^b   Benedetti, Antonio ^b   Marucci, Luca ^b   Solforosi, Laura ^b   Di Sario, Antonio ^b   Brunelli, Eugenio ^b   Orlandi, Francesco ^b   Clementi, Massimo ^b   Macarri, Giampiero ^b  

^a Ospedale Regionale Torrette   (Italy)

^b NONE

Author keywords

Fibrosis; HCV; Hepatic stellate cells; Interferon gamma; Viral load

Indexed keywords

ALPHA ACTIN; GAMMA INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; HELPER CELL; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LIVER FIBROSIS; LIVER INJURY; MALE; MORPHOMETRICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; STELLATE CELL; VIRUS LOAD;

ACTINS; ADULT; AGED; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON TYPE II; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NECROSIS; RNA, VIRAL; TH1 CELLS;

EID: 0033052304     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00038.x     Document Type: Article

References (42)

1. FRIEDMAN S L. The cellular basis of hepatic fibrosis. N Engl J Med 1993; 25: 1828-35.
2. SVEGLIATI BARONI G, D' AMBROSIO L, CURTO P, et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 1996; 23: 1189-99.
3. MILANI S, HERBST H, SCHUPPAN D, et al. Cellular localization of type I, III and IV procollagen gene transcripts in normal and fibrotic human liver. Am J Pathol 1990; 137: 59-70.
4. SVEGLIATI BARONI G, D' AMBROSIO L, FERRETTI G, et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 1998; 27: 720-6.
5. GONZALEZ-PERALTA R P, DAVIS G L, LAU J Y N. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol 1994; 21: 255-9.
6. LAU J Y N, DAVIS G L, KNIFFEN J, et al. Significance of serum hepatitis C virus (HCV) RNA levels in chronic HCV infection. Lancet 1993; 341: 1501-4.
7. ZEUZEM S, FRANKE A, LEE J H, et al. Phylogenstic analysis of hepatitis C virus isolates and their correlation to viremia, liver functions tests, and histology. Hepatology 1996; 24: 1003-9.
8. SCHEUER P J, ASHRAFZADEH P, SHERLOCK S, et al. The pathology of hepatitis C. Hepatology 1992; 15: 567-71.
9. MOSNIER J F, DEGOTT C, MARCELLIN P, et al. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology 1993; 17: 366-71.
10. MOSMANN T R, CHERWINSKI H, BOND M W, et al. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-57.
11. CLERICI M, SHEARER G M. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994; 15: 575-81.
12. CACCIARELLI T V, MARTINEZ O M, GISH R G, et al. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre-and posttreatment with interferon alfa. Hepatology 1996; 24: 6-9.
13. TSAI S L, LIAW Y F, CHEN M H, et al. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997; 25: 449-58.
14. BERTOLETTI A, D' ELIOS M M, BONI C, et al. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenteralogy 1997; 112: 193-9.
15. NAPOLI J, BISHOP G A, MCGUINNESS P H, et al. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996; 24: 759-65.
16. ISHAK K, BAPTISTA A, BIANCHI L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
17. CHOMCZYNSKI P, SACCHI N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 161: 156-9.
18. OKAMOTO H, SUGIYAMA Y, OKADA S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-9.
19. SILINI E, BONO F, CERINO A, et al. Virological features of hepatitis C virus infections in hemodialysis patients. J Clin Microbiol 1993; 31: 2913-7.
20. MANZIN A, BAGNARELLI P, MENZO S, et al. Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol 1994; 32: 1939-44.
21. GEERTS A, NIKI T, HELLEMANS K, et al. Purification of rat hepatic stellate cells by side scatter-activated cell sorting. Hepatology 1998; 27: 590-8.
22. SCHMITT-GRAFF A, KRUGER A, BOCHARD F, et al. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human liver. Am J Pathol 1991; 138; 1233-42.
23. NOUCHI T TANAKA Y, TSUKADA T, et al. Appearance of α-smooth-muscle-actin-positive cells in hepatic fibrosis. Liver 1991; 11: 100-4.
24. RAMM G A, CRAWFORD D H G, POWELL L W, et al. Hepatic stellate cells activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 1997; 26: 584-92.
25. YAMAOKA K, TOSHIHIKO N, MARUMO F, SATO C. α-smooth muscle actin expression in normal and fibrotic human livers. Dig Dis Sci 1993; 8: 1473-9.
26. REEVES H L, BURT A D, WOOD S, DAY C P. Hepatic stellate cells activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J Hepatol 1996; 25: 677-83.
27. GUIDO M, RUGGE M, LEANDRO G, et al. Hepatic stellate cells immunodetection and cirrhotic evolution of viral hepatitis in liver allograft. Hepatology 1997; 26: 310-4.
28. HOUGLUM K, VENKATARAMANI A, LYCHE K, CHOJKIER M. A pilot study of the effects of d-a-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology 1997; 113: 1069-73.
29. GUIDO M, RUGGE M, CHEMELLO L, et al. Liver stellate cells m chronic viral hepatitis: the effect of interferon therapy. J Hepatol 1996; 24: 301-7.
30. KAY E W, O' DOWD J, THOMAS R, et al. Mild abnormalities in liver histology associated with chronic hepatitis: distinction from normal liver histology. J Clin Pathol 1997; 50: 929-31.
31. KNODELL R G, ISHAK K G, BLACK W C, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-35.
32. ROMEO R, COLOMBO M, RUMI M, et al. Lack of association between type of hepatitis C virus, serum load and severity of liver disease. J Viral Hepat 1996; 3: 183-90.
33. PUOTI C, MAGRINI A, STATI T, et al. Clinical, histological and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 1997; 26: 1393-8.
34. DE MOLINER L, PONTISSO P, DE SALVO G L, et al. Serum and liver HCV-RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features. Gut 1998; 42: 856-60.
35. HOLLINGSWORTH R C, SILLEKENS P, VAN DEURSEN P, et al. Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time and lack of correlation with liver disease. The Trent HCV Study Group. J Hepatol 1996; 25: 301-6.
36. ASANZA C G, GARCIA-MONZON C, CLEMENTE G, et al. Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation. Hepatology 1997; 26: 755-63.
37. MCGUINNESS P H, BISHOP G A, PAINTER D M, et al. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology 1996; 23: 676-87.
38. MIHM S, FAYYAZI A, RAMADORI G. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury. Hepatology 1997; 26: 451-8.
39. LAU G K K, DAVIS G L, WU S P C, et al. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction. Hepatology 1996; 23: 1318-23.
40. DE MAEYER E, DE MAEYER-GUIGNARD J. Interferons. In: Thomas A ed. The cytokine handbook. London: Academic, 1991, 215-39.
41. CZAJA M J, WEINER F R, TAKAHASHI S, et al. Interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 1989; 10: 795-800.
42. SAKAIDA I, UCHIDA K, MATSUMURA Y, OKITA K. Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-β1 expression in pig serum-induced rat liver fibrosis in vivo. J Hepatol 1998; 28: 471-9.